Production of plasma proteins for therapeutic use
I tiakina i:
| Kaituhi rangatōpū: | |
|---|---|
| Ētahi atu kaituhi: | , , |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Hoboken, N.J. :
John Wiley & Sons,
c2013.
|
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Rārangi ihirangi:
- section 1. Introduction to plasma fractionation
- section 2. Plasma proteins for therapeutic use
- section 3. Pathogen safety of plasma products
- section 4. The pharmaceutical environment applied to plasma fractionation
- section 5. The market for plasma products and the economics of fractionation.